which one?
- Ryoncil BLA resubmission accepted by the FDA, with the 6 month review clock officially started
- CHF approval pathway clarified by the FDA, single trial approval pathway or second trial needed. With either pathway resulting in a CHF partnership ex-China later in the year.
- COVID 19 ARDS phase 3 trial funded and initiated by the NIH
- CLBP second phase 3 trial initiated
MSB Trading 2022, The TurnAround, page-368
-
- There are more pages in this discussion • 681 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
0.045(4.00%) |
Mkt cap ! $1.335B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.18 | $1.13 | $4.980M | 4.315M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 73090 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 27903 | 1 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |